Clinical Trial Update: A Study To Evaluate the Relative Bioavailability, Food Effect, and Dose Proportionality of a Granule Formulation of Vanzacaftor/Tezacaftor/Deutivacaftor(VNZ/TEZ/D-IVA) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating relative bioavailability, food effect, and dose proportionality of a granule formulation of Vanzacaftor/Tezacaftor/Deutivacaftor (D-IVA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Vanzacaftor/Tezacaftor/Deutivacaftor (D-IVA)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED